InMed Pharmaceuticals’ Eric Hsu, Senior Vice President of Preclinical Research and Development, will join the panel discussion “Pharmaceutical Cannabinoids and their Impact on Treatments for Complex Diseases”

To learn more about the Benzinga Healthcare Conference and tune into the panel discussion, join here: https://www.benzinga.com/events/small-cap/healthcare/

InMed Pharmaceuticals will report financial results for the fiscal year ended June 30, 2021, on Friday, September 24, 2021.

US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745
US/CANADA Participant International Dial-In Number: +1 (914) 987-7959
Conference ID: 9373618
Webcast: https://edge.media-server.com/mmc/p/ny89uo2r
(*Webcast replay available for 90 days)

The Company’s full financial statements and related MD&A for the fiscal year ended June 30, 2021 will be available at www.inmedpharma.com, www.sedar.com and at www.sec.gov on September 24, 2021.

Eric A. Adams, CEO of InMed, and Shane Johnson, Co-Founder of BayMedica, will present at Tribe Public’s Webinar Presentation and Q&A event titled “Accelerating The Commercialization of Rare Cannabinoids”.

To register to join the complimentary, ZOOM webinar-based event, please visit Tribe Public LLC at INM.TribePublic.com. Once registered, participants may begin forwarding their questions for InMed’s & BayMedica’s management to Tribe Public at [email protected]com or share their questions via the ZOOM chat feature during the event. Tribe Public’s Managing Member, John F. Heerdink, Jr., will host the event.

Meetings: InMed’s management team will also be conducting meetings with institutional investors throughout the conference. To schedule a meeting, please contact your H.C. Wainwright representative or register for the event at HCW Events.

Presentation details: 
InMed’s presentation will be available on demand to registered attendees during the conference, starting June 10th at 9am ET. InMed’s presentation can be accessed from the BIO Digital website at https://www.bio.org/events/bio-digital/sessions/800498.

To schedule 1×1 meetings with InMed, please do so through the BIO One on One Partnering System.

Presentation Details: In this live webinar, Eric Adams and Bruce Colwill will present an overview of the company’s recent operating and financial activities, followed by a Q&A session.
Register here.

Presentation available on demand from the H.C. Wainwright Events Platform: InMed presentation

An archived replay of the presentation will be available on the Company’s website immediately following the conference and will be available for 90 days.

Meetings: InMed’s management team will also be conducting meetings with institutional investors throughout the conference. To schedule a meeting, please contact your H.C. Wainwright representative or register for the event at HCW Events.

Presentation Details: InMed’s President and CEO, Eric A. Adams, will be presenting at Canaccord Genuity’s 5th Annual Global Cannabis Conference, which will be held virtually this year.
Register here.

To schedule a 1×1 meeting, please do so through the conference portal or reach out to [email protected].

Presentation Details: The company presentation will be available on demand beginning March 9^th at 7am EST, and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event.
Presentation Link: https://journey.ct.events/view/d9d5aa94-1651-4380-9c75-b8bf018118e6